Download Free Sample Report

Neuroscience Antibody Market, Global Outlook and Forecast 2024-2030

Neuroscience Antibody Market, Global Outlook and Forecast 2024-2030

  • Published on : 05 June 2024
  • Pages :72
  • Report Code:SMR-7957720

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global Neuroscience Antibody market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The USA market for Global Neuroscience Antibody market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Neuroscience Antibody market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Neuroscience Antibody market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Antibodies Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Neuroscience Antibody include Abcam, BioLegend, Bio-Rad Laboratories Inc, Cell Signaling Technology, Roche, Genscript Biotech Corp, Merck KGaA, Rockland Immunochemicals Inc and Santa Cruz Biotechnology Inc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Neuroscience Antibodies are major tools to clarify the process and mechanism which take place during neural development and related disease. The key to neuroscience research is the identification of cellular, molecular and tissue features that can be used as biomarkers to help identify patients at risk for neurological disease and as targets for new therapies.
This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibody. This report contains market size and forecasts of Neuroscience Antibody in global, including the following market information:
Global Neuroscience Antibody Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Neuroscience Antibody Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Neuroscience Antibody companies in 2023 (%)

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuroscience Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuroscience Antibody Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Neuroscience Antibody Market Segment Percentages, by Type, 2023 (%)

  • Antibodies
  • Research Reagents

Global Neuroscience Antibody Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Neuroscience Antibody Market Segment Percentages, by Application, 2023 (%)

  • Hospitals and Diagnostics Centers
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies

Global Neuroscience Antibody Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Neuroscience Antibody Market Segment Percentages, By Region and Country, 2023 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

  • Key companies Neuroscience Antibody revenues in global market, 2019-2024 (Estimated), ($ millions)
  • Key companies Neuroscience Antibody revenues share in global market, 2023 (%)
  • Key companies Neuroscience Antibody sales in global market, 2019-2024 (Estimated), (K Units)
  • Key companies Neuroscience Antibody sales share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Abcam
  • BioLegend
  • Bio-Rad Laboratories Inc
  • Cell Signaling Technology
  • Roche
  • Genscript Biotech Corp
  • Merck KGaA
  • Rockland Immunochemicals Inc
  • Santa Cruz Biotechnology Inc
  • Siemens Healthineers
  • Tecan Group Ltd
  • Thermo Fisher Scientific Inc
  • Enzo Life Sciences AG
  • Neobioscience

Outline of Major Chapters:
Chapter 1: Introduces the definition of Neuroscience Antibody, market overview.
Chapter 2: Global Neuroscience Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of Neuroscience Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neuroscience Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Neuroscience Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.